Industry Advocacy

A Matrix Global Advisors report highlights current barriers and recommendations for robust competition and patient savings in the next decade.

Conway will keynote the Political Action Committee Breakfast during the 2025 NACDS Annual Meeting, set for April 26-29 in Palm Beach, Fla.

Anticompetitive PBM tactics lead to higher costs, limited choices and pharmacy deserts, Chancy said.

Jim Whitman announced he will retire in June after nearly five decades at NACDS.

NACDS is urging members to watch The House Energy and Commerce Health Subcommittee's hearing on pharmacy benefit manager tactics on Feb. 26 at 10:00 am ET.

The recommendations are a call to action to safeguard affordable generic and biosimilar medicines.

AAM said the report highlights that 90% of the brand biologics scheduled to lose exclusivity in the next 10 years do not have biosimilars in development.

Building on the success during the COVID-19 pandemic, independent community pharmacies are taking steps to enhance their readiness for future public health emergencies.